Spinocerebellar ataxia type 13 mutation that is associated with disease onset in infancy disrupts axonal pathfinding

Fadi A Issa1, Allan F Mock, Alvaro Sagasti

  • 1Department of Physiology, University of California at Los Angeles, Los Angeles, CA 90095-1751, USA.

Insights

Spinocerebellar ataxia type 13 (SCA13) mutations in Kv3.3 channels disrupt motor neuron development. Infant-onset mutations cause axon pathfinding errors, while adult-onset mutations alter axonal arbor complexity, impacting SCA13 onset.

Area of Science:

  • Neuroscience
  • Genetics
  • Developmental Biology

Background:

  • Spinocerebellar ataxia type 13 (SCA13) is an autosomal dominant disorder linked to Kv3.3 potassium channel mutations.
  • SCA13 presents as infant-onset (severe cerebellar atrophy, intellectual disability) or adult-onset (progressive ataxia, degeneration).

Purpose of the Study:

  • To investigate how infant- and adult-onset SCA13 mutations differentially affect neuronal development.
  • To understand the role of Kv3.3 channel function in motor neuron development and SCA13 pathogenesis.

Main Methods:

  • Expressed wild-type and mutant Kv3.3 proteins (infant- and adult-onset) in zebrafish motor neurons (CaP).
  • Analyzed motor neuron development using confocal microscopy and 3D reconstruction at ~36 and ~48 hours post-fertilization.

Main Results:

  • Infant-onset Kv3.3 mutations led to significant CaP motor neuron axon pathfinding errors.
  • Adult-onset Kv3.3 mutations increased distal axonal arbor complexity but did not cause pathfinding errors.
  • Wild-type Kv3.3 expression had no significant effect on motor neuron development.

Conclusions:

  • Differential effects of Kv3.3 mutations on neuronal development may explain the varying onset ages of SCA13.
  • Infant-onset mutations' pathfinding errors could contribute to early-life cerebellar degeneration in SCA13.
  • Adult-onset mutations' effects on axonal complexity may relate to progressive cerebellar degeneration in later-onset SCA13.

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Neurulation01:30

Neurulation

Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the anterior...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...